시장보고서
상품코드
1532820

임상 미생물학 시장 : 제품별, 용도별, 질병별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Clinical Microbiology Market, By Product, By Application, By Disease, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 348 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

임상 미생물학 시장 규모는 2024년 46억 870만 달러로 2024-2032년 연평균 6.22% 성장할 것으로 예상됩니다.

임상 미생물학 시장 - 시장 역학

촉진인자 기술의 발전으로 임상 미생물 검사에서 질병 진단 강화

의료 관련 감염(HAI)이 확산됨에 따라, 의료 현장에서 HAI를 관리하는 것이 점점 더 중요해지고 있습니다. 첨단 분자진단 기술의 채택이 증가하면서 병원체 관련 질병을 조기에 발견하고 효과적으로 치료할 수 있게 되었습니다. 이전의 수작업 방식과 달리, 최신 자동화된 미생물 동정 및 감수성 검사 절차는 보다 빠르고 정확한 결과를 제공합니다. 차세대 염기서열 분석(NGS), 실시간 중합효소 연쇄 반응(PCR), 분자 카트리지, 질량 분석 등 최첨단 기술을 활용하여 미생물을 정확하게 식별하고 항생제 감수성을 판단할 수 있습니다. 감염 관리에 대한 수요 증가와 최종사용자의 선호도에 따라 주요 제조업체들은 첨단 분자진단 제품 개발에 주력하고 있습니다.

정부 통계는 이러한 변화의 시급성을 강조합니다. 미국 질병예방통제센터(CDC)에 따르면, 미국에서는 병원 환자 31명 중 1명이 하루에 한 번 이상 HAI에 감염됩니다. National Healthcare Safety Network(NHSN)는 첨단 진단 기술의 채택으로 HAI 발생률이 크게 감소했다고 보고하고 있습니다. 예를 들어, PCR과 NGS의 사용으로 병원체 동정 및 감수성 검사에 소요되는 시간이 50% 단축되어 HAI 대응에 있어 기술 발전의 중요한 역할을 강조하고 있습니다.

임상 미생물학 시장 - 주요 인사이트

당사의 리서치 분석가들은 2024-2032년 동안 세계 시장이 약 6.22%의 CAGR로 성장할 것으로 예측하고 있습니다.

제품별로는 임상시험 장비 부문이 가장 큰 시장 점유율을 차지하고 있습니다.

용도별로는 의약품 용도가 가장 큰 비중을 차지하며 가장 빠르게 성장하고 있습니다.

질병 유형별로는 호흡기 질환이 시장을 독점하고 있습니다.

최종사용자별로는 병원과 진단센터가 가장 높은 시장 점유율을 차지하고 있습니다.

지역별로는 북미가 2023년 매출을 주도하고 있습니다.

임상 미생물학 시장 - 세분화 분석:

임상 미생물학 시장은 용도, 질병, 제품, 최종사용자 및 지역을 기준으로 세분화됩니다. 시장은 테스트 기기, 자동 배양 시스템, 시약의 세 가지 범주로 나뉩니다. 기기 부문이 가장 큰 시장 점유율을 차지하고 있으며, 학술 부문에서의 광범위한 사용, 첨단 기술 기술, 단백질체학, 실험실 자동화 등이 그 요인으로 작용하고 있습니다.

임상 미생물학 시장 - 지리적 인사이트

지역별로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 존재합니다. 이 구역은 어떤 국가가 사업을 가져오는지에 따라 더 세분화되며, 북미는 2023년 매출 점유율이 39.28 %로 시장의 가장 큰 부분을 차지할 것입니다. 미국 시장은 의료 환경을 재구성하는 다양한 힘에 의해 빠르게 성장하고 있습니다. 질병의 진단, 감시 및 관리에서 임상 미생물학의 중요한 역할은 전염병의 증가와 새로운 병원균으로 인한 지속적인 문제로 인해 부각되고 있습니다. 신속하고 정확한 검사 기술을 중시하는 분자진단학으로의 업계 변화는 분명하며, 바이오메리외(bioMerieux, B.D.), 다나허 코퍼레이션(Danaher Corporation)과 같은 기업들은 미생물 검사 시간을 단축하고 특이성을 높이며 민감도를 향상시킬 수 있는 새로운 기술을 도입하기 위해 연구개발에 지속적으로 투자하고 있습니다.

임상 미생물학 시장 - 경쟁 상황:

임상 미생물학 시장에는 강력한 경쟁 구도가 존재합니다. 이 시장의 주요 진입자로는 BioMerieux, Danaher Corporation, Becton, Dickinson, and Company (BD) (US), Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (US) and Agilent Technologies, Inc. (US) 등이 있습니다.

목차

제1장 임상 미생물학 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 임상 미생물학의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 임상 미생물학 산업 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 프레임워크 분석

제5장 임상 미생물학 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 임상 미생물학 시장 상황

  • 임상 미생물학 시장 점유율 분석, 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 임상 미생물학 시장 - 제품별

  • 개요
    • 제품별 부문 점유율 분석
    • 자동 배양 시스템
      • 분자진단 기기
      • 현미경
      • 미생물 분석기
      • 질량분석계
    • 실험 기구
      • 그람 염색기
      • 세균 콜로니 카운터
      • 인큐베이터
      • 오토클레이브 멸균기
      • 페트리 접시 충전제
    • 시약

제8장 임상 미생물학 시장 - 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 의약품 용도
    • 화학과 재료 제조 용도
    • 환경 용도
    • 임상 용도
    • 식품 시험 용도
    • 에너지 용도
    • 기타

제9장 임상 미생물학 시장 - 질환별

  • 개요
    • 질환별 부문 점유율 분석
    • 성감염증
    • 요로감염
    • 호흡기질환
    • 혈류 감염
    • 소화기질환
    • 치주질환
    • 기타

제10장 임상 미생물학 시장 - 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 병원과 진단 센터
    • 학술연구기관
    • 커스텀 실험실 서비스 프로바이더
    • 기타

제11장 임상 미생물학 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 - 임상 미생물학 업계

  • 경쟁 대시보드
  • 기업 개요
    • BioMerieux
    • Thermo Fisher Scientific
    • Becton, Dickinson and Company(BD)
    • Danaher Corporation
    • Roche Diagnostics
    • Bruker Corporation
    • Hologic, Inc.
    • QIAGEN NV
    • Abbott Laboratories
    • Bio-Rad Laboratories
    • Cepheid(part of Danaher)
    • Siemens Healthineers
    • Luminex Corporation
    • Agilent Technologies
    • Merck KGaA
    • 기타

제13장 애널리스트의 전방위 전망

ksm 24.09.03

REPORT HIGHLIGHT

Clinical Microbiology Market size was valued at USD 4,608.7 Million in 2024, expanding at a CAGR of 6.22% from 2024 to 2032.

The study of identifying, characterizing, and quantifying bacteria from patients to aid in the diagnosis, treatment, and management of infectious diseases is known as clinical microbiology. The Clinical Microbiology market has experienced significant growth in the past few years and is expected to continue, driven by the factors such as surging incidences of infectious disease, growing awareness of early disease detection, and the development of innovative diagnostic techniques.

Clinical Microbiology Market- Market Dynamics

Driver: Technological Advancements Bolster Disease Diagnostics in Clinical Microbiology

As healthcare-associated infections (HAIs) become more prevalent, the management of these infections is increasingly critical in healthcare settings. The adoption of advanced molecular diagnostic techniques is on the rise, enabling early disease detection and effective treatment of pathogen-related illnesses. Unlike earlier manual methods, modern automated microbe identification and susceptibility testing procedures offer faster and more accurate results. Utilizing cutting-edge technologies such as Next Generation Sequencing (NGS), real-time Polymerase Chain Reaction (PCR), molecular cartridges, and mass spectrometry, these systems can precisely identify microorganisms and determine their antibiotic susceptibility. In response to the growing demand for infectious disease management and the preferences of end-users, leading manufacturers are focusing on developing advanced molecular diagnostic products.

Government statistics underline the urgency of this shift. According to the Centers for Disease Control and Prevention (CDC), approximately 1 in 31 hospital patients in the United States has at least one HAI on any given day. This translates to about 687,000 infections and 72,000 deaths annually in hospitals alone. The National Healthcare Safety Network (NHSN) has reported a significant decrease in the incidence of HAIs due to the adoption of advanced diagnostic technologies. For instance, the use of PCR and NGS has led to a 50% reduction in the time required for pathogen identification and susceptibility testing, highlighting the critical role of technological advancements in combating HAIs.

Clinical Microbiology Market- Key Insights

Our research analyst estimates that the global market will develop at a CAGR of approximately 6.22% from 2024 to 2032.

Based on Product segmentation, the Laboratory Instruments segment holds the largest market share.

Based on Application segmentation, the Pharmaceutical Application category is the largest and fastest-growing.

Based on Disease Type segmentation, the Respiratory Diseases segment dominates the market.

Based on End-user segmentation, Hospitals And Diagnostic Centers have the highest market share.

Based on region, North America was the leading revenue generator in 2023

Clinical Microbiology Market- Segmentation Analysis:

Clinical Microbiology Market is segmented based on Application, Disease, Product, End User, and Region. The market is divided into three categories: Laboratory Instruments, Automated Culture Systems, and Reagents. The Instruments segment holds the largest market share, fuelled by its extensive use in academia, advanced technological techniques, proteomics, and laboratory automation.

Clinical Microbiology Market- Geographical Insights

Geographically, this market is present in North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These zones are further split based on which countries bring business. With a revenue share of 39.28% in 2023, North America owned the largest part of the market. The U.S. market is expanding rapidly, driven by various forces that are reshaping the healthcare environment. The critical role of clinical microbiology in illness diagnosis, surveillance, and management is highlighted by the rising prevalence of infectious diseases and the continued problems provided by new pathogens. A change in the industry toward molecular diagnostics, with an emphasis on quick and precise testing techniques, is evident. Businesses like bioMerieux, B.D., and Danaher Corporation keep spending money on R&D to bring in new technologies that shorten turnaround times, boost specificity, and raise sensitivity in microbiological testing.

Clinical Microbiology Market- Competitive Landscape:

Clinical Microbiology Market has a strong competitive landscape. Major players in this market include BioMerieux, Danaher Corporation, Becton, Dickinson, and Company (BD) (US), Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (US) and Agilent Technologies, Inc. (US)

Recent Developments:

In May 2023, HiMedia Laboratories Pvt. Ltd. and Advanced Instruments LLC collaborated to introduce their newest innovation in microbiology research-the Anoxomat III Anaerobic Culture System.

In March 2023, bioMerieux SA in collaboration with its partner Interscience, introduced the 3P STATION, an automated system tailored to meet the specific requirements of pharmaceutical industry stakeholders. This automated system optimizes and ensures reliable reading performances and was created specially to satisfy the environmental monitoring requirements of the pharmaceutical industry.

In February 2023, bioMerieux SA launched MAESTRIA, a cutting-edge middleware designed for microbiology laboratories. With the help of this new-generation middleware, all routine activities in the microbiology lab will be managed through a single software tool.

In January 2023, Bruker acquired ACQUIFER Imaging GmbH, a provider of bioimaging and high-content microscopy solutions. This strategic move to strengthen Bruker's capabilities in microscopy

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL CLINICAL MICROBIOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

BioMerieux

Thermo Fisher Scientific

Becton, Dickinson and Company (BD)

Danaher Corporation

Roche Diagnostics

Bruker Corporation

Hologic, Inc.

QIAGEN N.V.

Abbott Laboratories

Bio-Rad Laboratories

Cepheid (part of Danaher)

Siemens Healthineers

Luminex Corporation

Agilent Technologies

Merck KGaA

Others

GLOBAL CLINICAL MICROBIOLOGY MARKET, BY PRODUCT - MARKET ANALYSIS, 2024- 2032

  • Automated Culture System
  • Molecular Diagnostic Instruments
  • Microscopes
  • Microbiology Analyzers
  • Mass Spectrometers
  • Laboratory Instruments
  • Gram Stainers
  • Bacterial Colony Counters
  • Incubators
  • Autoclave Sterilizers
  • Petri Dish Fillers
  • Reagents

GLOBAL CLINICAL MICROBIOLOGY MARKET, BY APPLICATION - MARKET ANALYSIS, 2024 - 2032

  • Pharmaceutical Applications
  • Chemical and Material Manufacturing Applications
  • Environmental Applications
  • Clinical Applications
  • Food Testing Applications
  • Energy Applications
  • Others

GLOBAL CLINICAL MICROBIOLOGY MARKET, BY DISEASE- MARKET ANALYSIS, 2024 - 2032

  • Sexually Transmitted Diseases
  • Urinary Tract Infections
  • Respiratory Diseases
  • Bloodstream Infections
  • Gastrointestinal Diseases
  • Periodontal Diseases
  • Other Diseases

GLOBAL CLINICAL MICROBIOLOGY MARKET, BY END USER - MARKET ANALYSIS, 2024 - 2032

  • Hospitals and Diagnostic Centers
  • Academic and Research Institutes
  • Custom Lab Service Providers
  • Others

GLOBAL CLINICAL MICROBIOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2024 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Clinical Microbiology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Clinical Microbiology Market Snippet by Product
    • 2.1.2. Clinical Microbiology Market Snippet by Application
    • 2.1.3. Clinical Microbiology Market Snippet by Disease
    • 2.1.4. Clinical Microbiology Market Snippet by End User
    • 2.1.5. Clinical Microbiology Market Snippet by Country
    • 2.1.6. Clinical Microbiology Market Snippet by Region
  • 2.2. Competitive Insights

3. Clinical Microbiology Key Market Trends

  • 3.1. Clinical Microbiology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Clinical Microbiology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Clinical Microbiology Market Opportunities
  • 3.4. Clinical Microbiology Market Future Trends

4. Clinical Microbiology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Clinical Microbiology Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Clinical Microbiology Market Landscape

  • 6.1. Clinical Microbiology Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Clinical Microbiology Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Automated Culture System
      • 7.1.2.1. Molecular Diagnostic Instruments
      • 7.1.2.2. Microscopes
      • 7.1.2.3. Microbiology Analyzers
      • 7.1.2.4. Mass Spectrometers
    • 7.1.3. Laboratory Instruments
      • 7.1.3.1. Gram Stainers
      • 7.1.3.2. Bacterial Colony Counters
      • 7.1.3.3. Incubators
      • 7.1.3.4. Autoclave Sterilizers
      • 7.1.3.5. Petri Dish Fillers
    • 7.1.4. Reagents

8. Clinical Microbiology Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Pharmaceutical Applications
    • 8.1.3. Chemical and Material Manufacturing Applications
    • 8.1.4. Environmental Applications
    • 8.1.5. Clinical Applications
    • 8.1.6. Food Testing Applications
    • 8.1.7. Energy Applications
    • 8.1.8. Others

9. Clinical Microbiology Market - By Disease

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
    • 9.1.2. Sexually Transmitted Diseases
    • 9.1.3. Urinary Tract Infections
    • 9.1.4. Respiratory Diseases
    • 9.1.5. Bloodstream Infections
    • 9.1.6. Gastrointestinal Diseases
    • 9.1.7. Periodontal Diseases
    • 9.1.8. Other Diseases

10. Clinical Microbiology Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2. Hospitals and Diagnostic Centers
    • 10.1.3. Academic and Research Institutes
    • 10.1.4. Custom Lab Service Providers
    • 10.1.5. Others

11. Clinical Microbiology Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Clinical Microbiology Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Clinical Microbiology Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Clinical Microbiology Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Clinical Microbiology Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Clinical Microbiology Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Clinical Microbiology Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. BioMerieux
    • 12.2.2. Thermo Fisher Scientific
    • 12.2.3. Becton, Dickinson and Company (BD)
    • 12.2.4. Danaher Corporation
    • 12.2.5. Roche Diagnostics
    • 12.2.6. Bruker Corporation
    • 12.2.7. Hologic, Inc.
    • 12.2.8. QIAGEN N.V.
    • 12.2.9. Abbott Laboratories
    • 12.2.10. Bio-Rad Laboratories
    • 12.2.11. Cepheid (part of Danaher)
    • 12.2.12. Siemens Healthineers
    • 12.2.13. Luminex Corporation
    • 12.2.14. Agilent Technologies
    • 12.2.15. Merck KGaA
    • 12.2.16. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제